尽管有人努力将美联储理事沃勒的反对票与美联储主席任命联系起来，但Pimco分析师Richard Clarida和 Apollo的分析师Torsten Slok都对沃勒投出的反对票持字面解读，认为这一决定纯粹是由于他对劳动力市 场的担忧所驱动。 ...

A property lender managed by Apollo agreed to sell its portfolio to the buyout firm’s insurance arm https://t.co/mteozLbqhN ...

In Going Private, our twice-weekly newsletter on private markets, we look at a rare loss for Apollo in private asset-backed finance https://t.co/rN70zpRBK3 ...

Today in Bloomberg Deals: Apollo’s Antoine Munfakh gives his 2026 predictions, Glencore tops list of European M&A targets and JPMorgan has a message for its advisory bankers. https://t.co/9E41n9mVt1 ...

Correction: Apollo took a loss on a portion of a $170 million asset-backed financing for Amazon brand aggregator Perch that was wiped out, a rare stumble for a strategy touted as one of private credit’s safest and most promising https://t.co/sMJ4YUxB9b ...

Apollo took a roughly $170 million hit after an asset-backed financing for Amazon brand aggregator Perch was wiped out, a rare stumble for a strategy touted as one of private credit’s safest and most promising https://t.co/dkfZfw72m4 ...

Core Insights - The transition from public markets to private capital revealed significant challenges in fund administration, particularly the reliance on fragmented and manually compiled data, which contrasts sharply with the real-time data access in hedge funds [1] - The rise of private markets and advancements in AI present an opportunity for innovation in fund administration software, aimed at improving efficiency for various investment firms [2][3] Group 1: Market Opportunity - The private investment sector is experiencing rapid growth, driven by private credit and high-value companies, creating a demand for improved fund administration solutions [3] - Existing fund administration options are largely unsatisfactory, leading many firms to resort to shadow fund administration practices, indicating a gap in the market for better solutions [4] Group 2: Product Development - The new software, named Formulary, aims to bridge the gap between high-touch accounting services and software solutions by leveraging AI to enhance efficiency and accuracy in fund administration [5] - The concept of "bionic accountants" is introduced, where in-house accountants utilize advanced software to manage data without the burdens of manual entry, addressing long-standing inefficiencies in the industry [5] Group 3: Funding and Support - Formulary has successfully secured a $4.6 million seed round led by Khosla Ventures, which was three times oversubscribed, indicating strong investor interest and confidence in the product [2]

Core Insights - Private fund assets have tripled over the past decade, significantly outpacing the public market's growth rate of over 2X, indicating a strong interest in private equity and credit among investors [2] - The ETF market for private assets is limited due to structural protections, with the SEC imposing a 15% limit on illiquid holdings, which affects the allocation of ETFs in this category [3][4] - Retail investors are increasingly interested in private equity, but there are few ETFs available that hold private equity assets, leading to considerations regarding valuation and fees associated with these investments [5] ETF Market Dynamics - Interval funds and semi-liquid products have been developed to provide access to private markets, with some ETFs like the SPDR SSGA IG Public & Private Credit ETF (PRIV) and State Street Short Duration IG Public & Private Credit ETF (PRSD) offering around 20% exposure to private credit [4] - The ERShares Private-Public Crossover ETF (XOVR) has gained attention for its 10% allocation to SpaceX, but concerns exist regarding the valuation of such holdings and the potential for high undisclosed fees [5] - Asset managers are focusing on investor education in the realms of private markets and ETFs, leading to increased hiring of product and portfolio specialists [5]

Core Viewpoint - The $1.8 billion takeover of Soho House has been revived with new funding commitments, allowing the company to proceed with a take-private deal with MCR Hotels [1][2]. Funding and Financial Arrangements - Soho House has secured a new $200 million funding commitment, which is crucial for closing the deal with MCR Hotels [1]. - Under the revised terms, Morse Ventures and MCR will each commit $50 million, while Soho House has extended its debt facilities from $150 million to $220 million [2]. - Major shareholders, including Richard Caring, have agreed to roll over their stakes, reducing the funding required for the deal by $50 million [2]. Market Reaction and Share Performance - The initial announcement of MCR's inability to provide the promised $200 million led to a drop in Soho House's stock price, which later rebounded after the new funding arrangement was confirmed [3]. Company Background and Growth - Soho House, founded in 1995, has expanded to 46 locations worldwide, but has faced challenges related to overcrowding and loss of exclusivity [4][7]. - The company temporarily halted membership applications in key cities but has since resumed accepting new members and opened new venues [8][9]. Deal Context and Historical Performance - The takeover deal is priced at $9 per share, representing an 83% premium over the company's recent share price, although it is significantly lower than the $13 per share at its IPO in July 2021 [5]. - MCR's recent acquisition of the BT Tower for £275 million is part of a broader strategy to transform the landmark into a hotel [6].

Core Viewpoint - Skyward Group has announced the global expansion of its Life Sciences insurance solution, leveraging Apollo's Lloyd's Syndicate 1969 to enhance multinational placements for U.S.-domiciled life sciences companies with international operations [1][2]. Group Overview - Skyward Group operates as a unified specialty insurance organization, encompassing Skyward Specialty and Apollo, and provides a comprehensive suite of specialized insurance solutions across global specialty property and casualty markets [3][4]. - The company focuses on niche and complex risks, aiming to drive sustainable growth and long-term value for shareholders and stakeholders [3]. Strategic Collaboration - The expansion of the Life Sciences product is the first strategic collaboration between Skyward Specialty and Apollo since the acquisition was finalized earlier in January 2026 [1][2]. - The collaboration is expected to leverage the complementary capabilities of both organizations, enhancing their ability to support specialty risks on a global scale [2]. Product Offerings - Skyward Specialty provides a range of commercial property and casualty products through nine underwriting divisions, including Accident & Health, Agriculture, and Professional Lines [5]. - The insurance companies under Skyward Specialty are rated A (Excellent) with a stable outlook by A.M. Best Company, indicating a strong financial position [6]. Apollo's Role - Apollo operates as an innovation-inspired insurance platform at Lloyd's of London, offering data-driven solutions across various risk categories, including Property, Casualty, and Specialty [7]. - The platform aims to provide high-quality products and services, enabling a resilient and sustainable world [7].